Global Cirrhosis Management Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Treatment;

Treating Cirrhosis Causes, Corticosteroids, Symptomatic Treatment, Analgesics, and Others.

By Disease Indication;

Alcoholic Liver Cirrhosis and Non-alcoholic Liver Cirrhosis.

By End User;

Hospitals, Ambulatory Surgical Centers, Research Institutes, Dialysis Centers, Clinics, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn139283469 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Cirrhosis Management Market (USD Million), 2021 - 2031

In the year 2024, the Global Cirrhosis Management Market was valued at USD 764.27 million. The size of this market is expected to increase to USD 994.81 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.8%.

The Global Cirrhosis Management Market addresses the complex and multifaceted challenges associated with cirrhosis, a chronic liver condition characterized by the progressive scarring and impairment of liver function. Cirrhosis represents a significant public health concern worldwide, with diverse etiologies such as chronic viral hepatitis, alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD), autoimmune liver diseases, and metabolic disorders. This condition can lead to severe complications, including portal hypertension, ascites, hepatic encephalopathy, variceal bleeding, and hepatocellular carcinoma (HCC), necessitating comprehensive management strategies to mitigate disease progression, improve patient outcomes, and enhance quality of life.

The management of cirrhosis encompasses a continuum of care aimed at preventing liver decompensation, managing complications, addressing underlying liver disease etiologies, and promoting liver regeneration and function. Treatment modalities may include lifestyle modifications, pharmacotherapy, interventional procedures, and liver transplantation, tailored to individual patient needs and disease severity. Lifestyle modifications such as abstinence from alcohol, smoking cessation, weight management, and adherence to a balanced diet are essential components of cirrhosis management, aiming to reduce liver injury, metabolic derangements, and disease progression. Pharmacotherapy plays a critical role in managing complications of cirrhosis, such as diuretics for ascites, beta-blockers for variceal bleeding prophylaxis, and antiviral therapy for viral hepatitis, while addressing underlying etiologies contributing to liver damage.

Interventional procedures such as transjugular intrahepatic portosystemic shunt (TIPS) placement, paracentesis, and endoscopic variceal band ligation (EVBL) are utilized to alleviate symptoms and complications associated with advanced cirrhosis, improve hemodynamic abnormalities, and reduce the risk of life-threatening events. Liver transplantation represents the definitive treatment for end-stage cirrhosis and liver failure, offering a chance for long-term survival and improved quality of life in eligible patients. The Global Cirrhosis Management Market encompasses a diverse array of healthcare providers, including hepatologists, gastroenterologists, transplant surgeons, interventional radiologists, and allied healthcare professionals, collaborating to deliver comprehensive and multidisciplinary care to patients with cirrhosis. Through innovative therapeutic approaches, advancements in medical technology, and concerted efforts in disease prevention and management, the Global Cirrhosis Management Market aims to address the growing burden of cirrhosis and improve patient outcomes on a global scale.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment
    2. Market Snapshot, By Disease Indication
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Cirrhosis Management Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Liver transplantation
        2. Complication management
        3. Lifestyle modifications
      2. Restraints
        1. Liver Transplantation
        2. Treatment Cost
        3. Limited Resources
      3. Opportunities
        1. Liver Transplantation
        2. Interventional Procedures
        3. Pharmacotherapy Advancements
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Cirrhosis Management Market, By Treatment, 2021 - 2031 (USD Million)
      1. Treating Cirrhosis Causes
      2. Corticosteroids
      3. Symptomatic Treatment
      4. Analgesics
      5. Others
    2. Global Cirrhosis Management Market, By Disease Indication, 2021 - 2031 (USD Million)
      1. Alcoholic Liver Cirrhosis
      2. Non-alcoholic Liver Cirrhosis
    3. Global Cirrhosis Management Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Research Institutes
      4. Dialysis Centers
      5. Clinics
      6. Others
    4. Global Cirrhosis Management Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. B. Braun Medical Inc.
      2. Alliancells Bioscience Corporation Ltd.
      3. Histogen Inc.
      4. Stempeutics Research Pvt. Ltd.
      5. Epic Research & Diagnostics Inc.
      6. Theravance Biopharma R&D Inc.
      7. Sequana Medical AG
  7. Analyst Views
  8. Future Outlook of the Market